<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Aluminium</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01370</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01370/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01370/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01370.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01370.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01370.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01370.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01370.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01370">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>7429-90-5</td></tr><tr><th>Weight</th><td>Average: 26.9815386<br>Monoisotopic: 26.981538441</td></tr><tr><th>Chemical Formula</th><td>Al</td></tr><tr><th>InChI Key</th><td>XAGFODPZIPBFFR-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/Al</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">alumane</div></td></tr><tr><th>SMILES</th><td><div class="wrap">[Al]</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Inorganic Compounds</td></tr><tr><th>Superclass</th><td>Homogeneous Metal Compounds</td></tr><tr><th>Class</th><td>Homogeneous Post-transition Metal Compounds</td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td>Homogeneous Post-transition Metal Compounds</td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td>This compound belongs to the homogeneous post-transition metal compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a post-transition metal atom.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pharmacodynamics</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mechanism of action</th><td>Aluminum Acetate is an astringent.  An astrignent is a chemical that tends to shrink or constrict body tissues, usually locally after topical medicinal application.  The shrinkage or constriction is through osmotic flow of water (or other fluids) away from the area where the astringent was applied.  Astringent medicines cause shrinkage of mucous membranes or exposed tissues and are often used internally to check discharge of blood serum or mucous secretions. This can happen with a sore throat, hemorrhages, diarrhea, or with peptic ulcers. Externally applied astringents, which cause mild coagulation of skin proteins, dry, harden, and protect the skin. Acne sufferers are often advised to use astringents if they have oily skin. Astringents also help heal stretch marks and other scars. Mild astringent solutions are used in the relief of such minor skin irritations as those resulting from superficial cuts, allergies, insect bites, or fungal infections such as athlete's foot. </td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9838</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9733</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.7354</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.881</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9787</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9858</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9108</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8305</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8255</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.8145</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8813</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9392</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9716</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9571</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9855</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.882</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.9633
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Carcinogens  
        </td>
        <td>
            0.664
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.7326
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.0135 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9547
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9746
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Aerosol</td><td>Oral</td><td></td></tr><tr><td>Aerosol</td><td>Topical</td><td></td></tr><tr><td>Capsule</td><td>Oral</td><td></td></tr><tr><td>Cream</td><td>Topical</td><td></td></tr><tr><td>Emulsion</td><td>Topical</td><td></td></tr><tr><td>Gel</td><td>Dental</td><td></td></tr><tr><td>Gel</td><td>Topical</td><td></td></tr><tr><td>Liquid</td><td>Dental</td><td></td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Liquid</td><td>Sublingual</td><td></td></tr><tr><td>Liquid</td><td>Topical</td><td></td></tr><tr><td>Lotion</td><td>Topical</td><td></td></tr><tr><td>Paste</td><td>Oral</td><td></td></tr><tr><td>Powder</td><td>Oral</td><td></td></tr><tr><td>Powder</td><td>Topical</td><td></td></tr><tr><td>Solution</td><td>Topical</td><td></td></tr><tr><td>Solution / drops</td><td>Oral</td><td></td></tr><tr><td>Spray</td><td>Topical</td><td></td></tr><tr><td>Stick</td><td>Topical</td><td></td></tr><tr><td>Suspension</td><td>Oral</td><td></td></tr><tr><td>Suspension</td><td>Topical</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>melting point</td><td>2.375 g&#183;cm &#8722;3</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>logP</td><td>1.45</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>1.78</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>1</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Bela Czegledi, Mihaly Csovari, Miklos Erdelyi, Lajos Streker, Istvan Toth, Katalin Szabo nee Mogyorosi, Szilard Riederauer, Geza Szentgyorgyi, &#8220;Process for producing alumina and ferric oxide from aluminium carriers with high iron and silicon content.&#8221; U.S. Patent US4366129, issued 1876.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=4366129&amp;tbm=pts" target="_blank">US4366129 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C06264" target="_blank">C06264 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5359268" target="_blank">5359268 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46504765" target="_blank">46504765 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.4514248.html" target="_blank">4514248 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=28984" target="_blank">28984 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000467" target="_blank">DAP000467 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA164760864" target="_blank">PA164760864 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=13838" target="_blank">13838 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Aluminium" target="_blank">Aluminium <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>A02AB07<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A02#A02">A02 &#8212; DRUGS FOR ACID RELATED DISORDERS</a></li><li><a href="/atc/A02A#A02A">A02A &#8212; ANTACIDS</a></li><li><a href="/atc/A02AB#A02AB">A02AB &#8212; Aluminium compounds</a></li></ul>A02AB03<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A02#A02">A02 &#8212; DRUGS FOR ACID RELATED DISORDERS</a></li><li><a href="/atc/A02A#A02A">A02A &#8212; ANTACIDS</a></li><li><a href="/atc/A02AB#A02AB">A02AB &#8212; Aluminium compounds</a></li></ul>D10AX01<ul class="atc-drug-tree"><li><a href="/atc/D#D">D &#8212; DERMATOLOGICALS</a></li><li><a href="/atc/D10#D10">D10 &#8212; ANTI-ACNE PREPARATIONS</a></li><li><a href="/atc/D10A#D10A">D10A &#8212; ANTI-ACNE PREPARATIONS FOR TOPICAL USE</a></li><li><a href="/atc/D10AX#D10AX">D10AX &#8212; Other anti-acne preparations for topical use</a></li></ul>C10AD04<ul class="atc-drug-tree"><li><a href="/atc/C#C">C &#8212; CARDIOVASCULAR SYSTEM</a></li><li><a href="/atc/C10#C10">C10 &#8212; LIPID MODIFYING AGENTS</a></li><li><a href="/atc/C10A#C10A">C10A &#8212; LIPID MODIFYING AGENTS, PLAIN</a></li><li><a href="/atc/C10AD#C10AD">C10AD &#8212; Nicotinic acid and derivatives</a></li></ul>C05AX01<ul class="atc-drug-tree"><li><a href="/atc/C#C">C &#8212; CARDIOVASCULAR SYSTEM</a></li><li><a href="/atc/C05#C05">C05 &#8212; VASOPROTECTIVES</a></li><li><a href="/atc/C05A#C05A">C05A &#8212; AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE</a></li><li><a href="/atc/C05AX#C05AX">C05AX &#8212; Other agents for treatment of hemorrhoids and anal fissures for topical use</a></li></ul>A02AB01<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A02#A02">A02 &#8212; DRUGS FOR ACID RELATED DISORDERS</a></li><li><a href="/atc/A02A#A02A">A02A &#8212; ANTACIDS</a></li><li><a href="/atc/A02AB#A02AB">A02AB &#8212; Aluminium compounds</a></li></ul>M05BX02<ul class="atc-drug-tree"><li><a href="/atc/M#M">M &#8212; MUSCULO-SKELETAL SYSTEM</a></li><li><a href="/atc/M05#M05">M05 &#8212; DRUGS FOR TREATMENT OF BONE DISEASES</a></li><li><a href="/atc/M05B#M05B">M05B &#8212; DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION</a></li><li><a href="/atc/M05BX#M05BX">M05BX &#8212; Other drugs affecting bone structure and mineralization</a></li></ul>D09AA08<ul class="atc-drug-tree"><li><a href="/atc/D#D">D &#8212; DERMATOLOGICALS</a></li><li><a href="/atc/D09#D09">D09 &#8212; MEDICATED DRESSINGS</a></li><li><a href="/atc/D09A#D09A">D09A &#8212; MEDICATED DRESSINGS</a></li><li><a href="/atc/D09AA#D09AA">D09AA &#8212; Medicated dressings with antiinfectives</a></li></ul>D10AX04<ul class="atc-drug-tree"><li><a href="/atc/D#D">D &#8212; DERMATOLOGICALS</a></li><li><a href="/atc/D10#D10">D10 &#8212; ANTI-ACNE PREPARATIONS</a></li><li><a href="/atc/D10A#D10A">D10A &#8212; ANTI-ACNE PREPARATIONS FOR TOPICAL USE</a></li><li><a href="/atc/D10AX#D10AX">D10AX &#8212; Other anti-acne preparations for topical use</a></li></ul>A02AB05<ul class="atc-drug-tree"><li><a href="/atc/A#A">A &#8212; ALIMENTARY TRACT AND METABOLISM</a></li><li><a href="/atc/A02#A02">A02 &#8212; DRUGS FOR ACID RELATED DISORDERS</a></li><li><a href="/atc/A02A#A02A">A02A &#8212; ANTACIDS</a></li><li><a href="/atc/A02AB#A02AB">A02AB &#8212; Aluminium compounds</a></li></ul>S02AA04<ul class="atc-drug-tree"><li><a href="/atc/S#S">S &#8212; SENSORY ORGANS</a></li><li><a href="/atc/S02#S02">S02 &#8212; OTOLOGICALS</a></li><li><a href="/atc/S02A#S02A">S02A &#8212; ANTIINFECTIVES</a></li><li><a href="/atc/S02AA#S02AA">S02AA &#8212; Antiinfectives</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>88:29.00*</li>
<li>34:00.00</li>
<li>56:04.00</li>
<li>52:28.00</li>
<li>84:12.00</li>
<li>92:02.00*</li>
<li>84:92.00</li>
<li>84:04.92</li>
<li>20:12.12</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00701">Amprenavir</a></td><td>The antiacid decreases the absorption of amprenavir</td></tr><tr><td><a href="/drugs/DB01072">Atazanavir</a></td><td>This gastric pH modifier decreases the levels/effects of atazanavir</td></tr><tr><td><a href="/drugs/DB00608">Chloroquine</a></td><td>The antiacid decreases the absorption of chloroquine</td></tr><tr><td><a href="/drugs/DB00537">Ciprofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01190">Clindamycin</a></td><td>The aluminium salt decreases the absorption of lincosamides</td></tr><tr><td><a href="/drugs/DB00720">Clodronate</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00250">Dapsone</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01609">Deferasirox</a></td><td>Possible physicochemical interaction</td></tr><tr><td><a href="/drugs/DB00705">Delavirdine</a></td><td>The antiacid decreases the effect of delavirdine</td></tr><tr><td><a href="/drugs/DB00618">Demeclocycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00254">Doxycycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01077">Etidronic acid</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01319">Fosamprenavir</a></td><td>The antiacid decreases the absorption of amprenavir</td></tr><tr><td><a href="/drugs/DB01044">Gatifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01155">Gemifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00365">Grepafloxacin</a></td><td>Formation of non-absorbable complexes </td></tr><tr><td><a href="/drugs/DB00710">Ibandronate</a></td><td>Formation of non absorbable complexes</td></tr><tr><td><a href="/drugs/DB00224">Indinavir</a></td><td>The antacid decreases the absorption of indinavir</td></tr><tr><td><a href="/drugs/DB01167">Itraconazole</a></td><td>Aluminum-containing antacids may decrease the effect of itraconazole.</td></tr><tr><td><a href="/drugs/DB01026">Ketoconazole</a></td><td>Aluminum-containing antacids may decrease the effect of ketoconazole.</td></tr><tr><td><a href="/drugs/DB01137">Levofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01627">Lincomycin</a></td><td>The aluminium salt decreases the absorption of lincosamides</td></tr><tr><td><a href="/drugs/DB01017">Minocycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00218">Moxifloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01059">Norfloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB01165">Ofloxacin</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00299">Penciclovir</a></td><td>The multivalent agent decreases the effect of penicillamine</td></tr><tr><td><a href="/drugs/DB01344">Polystyrene sulfonate</a></td><td>Risk of alkalosis in renal impairment</td></tr><tr><td><a href="/drugs/DB00759">Tetracycline</a></td><td>Formation of non-absorbable complexes</td></tr><tr><td><a href="/drugs/DB00685">Trovafloxacin</a></td><td>Aluminum may decrease the absorption of orally administered Trovafloxacin. Administer Trovafloxacin 2 hours before or 6 hours after a dose of the aluminum containing agent to minimize the interaction. </td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>